Expression and characterization of genetically engineered human immunodeficiency virus-like particles containing modified envelope glycoproteins: implications for development of a cross-protective AIDS vaccine.

Source:http://linkedlifedata.com/resource/pubmed/id/1602531

Download in:

View as

General Info

PMID
1602531